V. Malerczyk
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 26
- Antibiotics Pharmacokinetics and Efficacy 23
- Pharmacogenetics and Drug Metabolism 9
- Drug-Induced Adverse Reactions 4
-
- Antibiotic Resistance in Bacteria 9
- Co-authors
- A. Korn (7 shared papers)M. Verho (11 shared papers)Karl‐Heinz Lehr (4 shared papers)M. Badian (6 shared papers)W Waldhäusl (3 shared papers)Bernd Rosenkranz (5 shared papers)Claudia Lange (1 shared paper)Paul H. Heintzen (4 shared papers)
- Journals
- Infection (5 papers)Clinical Pharmacology & Therapeutics (2 papers)Chemotherapy (2 papers)Current Medical Research and Opinion (2 papers)European Journal of Clinical Pharmacology (2 papers)
- Partner nations
- GermanyBelgiumSouth Africa
In The Last Decade
V. Malerczyk
44 papers receiving 503 citations
Peers
Comparison fields: 5 of 84
- Molecular Medicine 102
- Pharmacology 262
- Pharmacology 74
- Clinical Biochemistry 54
- Applied Microbiology and Biotechnology 15
Countries citing papers authored by V. Malerczyk
This map shows the geographic impact of V. Malerczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Malerczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Malerczyk more than expected).
Fields of papers citing papers by V. Malerczyk
This network shows the impact of papers produced by V. Malerczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Malerczyk. The network helps show where V. Malerczyk may publish in the future.
Co-authors
The 25 scholars most cited alongside V. Malerczyk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 74 | |
| 2 | 1994 | 42 | |
| 3 | 1994 | 36 | |
| 4 | 1971 | 26 | |
| 5 | 1986 | 25 | |
| 6 | 1972 | 24 | |
| 7 | 1996 | 21 | |
| 8 | 1987 | 20 | |
| 9 | 1987 | 19 | |
| 10 | 1987 | 19 | |
| 11 | 1973 | 19 | |
| 12 | 1978 | 18 | |
| 13 | 1991 | 17 | |
| 14 | 1983 | 15 | |
| 15 | Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration. | 1987 | 15 |
| 16 | 1988 | 14 | |
| 17 | 1975 | 14 | |
| 18 | 1985 | 13 | |
| 19 | 1987 | 11 | |
| 20 | 1996 | 10 |
About V. Malerczyk
V. Malerczyk is a scholar working on Pharmacology, Pharmacology, Molecular Medicine, Pediatrics, Perinatology and Child Health and Oncology, having authored 46 papers that have together received 575 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Pharmacogenetics and Drug Metabolism (9 papers), Antibiotic Resistance in Bacteria (9 papers), Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (6 papers), Diabetes Treatment and Management (4 papers), Drug-Induced Adverse Reactions (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). The work is most often cited by research in Molecular Medicine (102 citations), Pharmacology (262 citations), Pharmacology (74 citations), Clinical Biochemistry (54 citations) and Applied Microbiology and Biotechnology (15 citations). V. Malerczyk has collaborated with scholars based in Germany, Belgium and South Africa. Frequent co-authors include A. Korn, M. Verho, Karl‐Heinz Lehr, M. Badian, W Waldhäusl, Bernd Rosenkranz, Claudia Lange, Paul H. Heintzen, Péter Hajdú and K. W. Scheel. Their work appears in journals such as Infection, Clinical Pharmacology & Therapeutics, Chemotherapy, Current Medical Research and Opinion and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.